| Income statement (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B |
| Cost of revenue | 3.42B | 2.72B | 2.39B | 2.03B | 1.75B | 1.50B |
| Gross profit | 6.64B | 5.63B | 4.73B | 4.20B | 3.96B | 2.86B |
| Research and development | 1.31B | 1.15B | 998.80M | 879.00M | 671.00M | 595.10M |
| Selling, general and admin | 2.38B | 2.14B | 1.96B | 1.74B | 1.47B | 1.22B |
| Operating expenses | 3.70B | 3.29B | 2.96B | 2.62B | 2.14B | 1.81B |
| Operating income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B |
| EBITDA | 3.55B | 2.79B | 2.15B | 1.90B | 2.10B | 1.27B |
| Income before tax | 3.31B | 2.67B | 1.96B | 1.61B | 1.89B | 1.21B |
| Income tax | 434.80M | 336.30M | 141.60M | 262.40M | 162.20M | 140.20M |
| Net income | 2.86B | 2.32B | 1.80B | 1.32B | 1.70B | 1.06B |
| EPS | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 |
| EPS (diluted) | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 |
| Diluted shares | 362.70M | 362.00M | 357.40M | 362.00M | 365.80M | 361.00M |
From Intuitive Surgical's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.